Healthcare Policy & Litigation

Since 2017, a primary focus for Liston & Deas has been working with state governments to analyze state spending on pharmaceuticals and achieve recoveries of state funds that have been wrongfully paid to Pharmacy Benefit Managers (“PBMs”), Managed Care Organizations, and other participants in the drug supply chain due to contractual non-adherence or other misconduct. During these efforts, we have built a robust team of data analysts, economists, and industry experts.

Please read our disclaimer.